Collaboration is an essential part of DNDi’s virtual R&D model: we cannot carry out our work without the engagement of public and private partners.
Today, DNDi has forged a diverse range of alliances and research collaborations with over 200 partners and service providers in more than 40 countries.
Industry partners and service providers
Amatsi Aquitaine (formerly Bertin Pharma)
Analytical Services International
Bayer Healthcare AG
Brazilian Biosciences National Laboratory (LNBio)
Cardiabase (Banook Group)
Charles River Laboratories (formerly WIL Research)
Hypha Discovery Ltd